PARNAX LAB
Sector : Pharmaceuticals and health care | Smallcap | BSE
Here's the live share price of Parnax Lab along with daily highs, lows, percentage changes and volume trends, and, all financial information.
-0.31₹ -0.4
As on Oct 31, 2025, 4:01 PM IST
Parnax Lab Price Performance
Today's LowToday's High
₹127.35₹136.00
₹129.00
52 Weeks' Low52 Weeks' High
₹81.00₹193.50
₹129.00
Open Price
₹136.00
Prev. Close
₹129.40
Volume
2,223
Over the last 5 years, the share price of Parnax Lab has gained 49.45% CAGR. Over the past year, the corresponding return has been -11.43%.
Parnax Lab’s current P/E of 13.71x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Best Pharmaceuticals and Healthcare Stocks Screener.
Parnax Lab Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Parnax Lab | -0.46 | 1.18 | 3.20 | 40.22 | -11.43 | 18.41 | 49.45 |
| Sun Pharmaceutical Industries | -0.57 | 3.28 | -0.92 | -7.60 | -8.61 | 18.48 | 29.21 |
| Divi's Laboratories | 2.65 | 18.41 | 2.45 | 10.85 | 14.73 | 23.31 | 17.28 |
| Cipla | -5.18 | -0.81 | -3.38 | -1.58 | -3.32 | 8.79 | 14.87 |
| Torrent Pharmaceuticals | -0.80 | -0.38 | -5.14 | 9.01 | 10.85 | 29.10 | 22.78 |
| Dr. Reddy's Laboratories | -6.61 | -3.78 | -5.65 | 1.37 | -5.90 | 10.60 | 4.30 |
| Mankind Pharma | -2.15 | -2.43 | -7.34 | -0.11 | -10.77 | 18.66 | 10.81 |
| Zydus Lifesciences | -3.15 | -1.79 | 0.41 | 10.00 | -2.78 | 30.95 | 18.88 |
| Lupin | 1.95 | -0.64 | 2.09 | -4.31 | -9.93 | 41.27 | 16.64 |
| Aurobindo Pharma | 4.93 | 4.74 | -0.20 | -6.06 | -18.43 | 28.36 | 8.42 |
| Alkem Laboratories | -0.73 | 0.83 | 9.42 | 8.53 | -4.81 | 20.39 | 15.68 |
| Abbott India | -3.15 | -2.92 | -15.75 | -5.70 | 0.08 | 14.62 | 13.33 |
| Glenmark Pharmaceuticals | 3.96 | -3.48 | -11.38 | 37.43 | 11.65 | 67.21 | 31.92 |
| Laurus Labs | 3.16 | 9.45 | 9.18 | 53.86 | 94.04 | 28.05 | 25.98 |
| Biocon | 3.58 | 7.36 | -4.88 | 16.74 | 17.67 | 11.37 | -1.64 |
| GlaxoSmithKline Pharmaceuticals | -4.58 | -2.61 | -16.91 | -8.00 | -3.51 | 23.97 | 13.24 |
| Anthem Biosciences | -1.31 | -7.94 | -6.37 | -2.73 | -2.73 | -0.92 | -0.55 |
| Ipca Laboratories | 0.17 | -4.35 | -13.80 | -7.87 | -20.02 | 11.98 | 2.00 |
| Gland Pharma | -0.60 | -2.66 | -6.66 | 37.25 | 16.79 | 2.61 | 1.15 |
| Ajanta Pharma | 2.22 | 2.85 | -10.32 | -4.54 | -19.69 | 23.86 | 18.63 |
Over the last one year, Parnax Lab has declined 11.43% compared to peers like Sun Pharmaceutical Industries (-8.61%), Divi's Laboratories (14.73%), Cipla (-3.32%). From a 5 year perspective, Parnax Lab has outperformed peers relative to Sun Pharmaceutical Industries (29.21%) and Divi's Laboratories (17.28%).
Parnax Lab Financials
Parnax Lab Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 129.9 | 130.36 |
| 10 | 129.44 | 130 |
| 20 | 128.53 | 129.76 |
| 50 | 130.41 | 128.17 |
| 100 | 121.02 | 123.97 |
| 200 | 116.1 | 120.96 |
Parnax Lab Share Holding Pattern
In the latest quarter, Parnax Lab remained same as its previous close in promoter holding, while DII stake unchanged at 0.00%, FII holding unchanged at 0.00%, and public shareholding moved up to 27.71% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Parnax Lab Corporate Actions
Date Time | Announcement |
|---|---|
| Oct 09, 2025, 10:29 PM IST | Parnax Lab L - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Oct 01, 2025, 4:54 AM IST | Parnax Lab L - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report |
| Sep 29, 2025, 11:31 PM IST | Parnax Lab L - Appointment Of HSPN Associates & LLP As Secretarial Auditor Of The Company. |
| Sep 29, 2025, 11:23 PM IST | Parnax Lab L - Shareholder Meeting / Postal Ballot-Outcome of AGM |
| Sep 06, 2025, 11:44 PM IST | Parnax Lab L - Reg. 34 (1) Annual Report. |
About Parnax Lab
Parnax Lab Ltd. is a Public Limited Listed company incorporated on 03/08/1982 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L36912MH1982PLC027925 and registration number is 027925. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company's Total Operating Revenue is Rs. 7.02 Cr. and Equity Capital is Rs. 11.49 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- AddressGala 114, Building No.8, Mumbai Maharashtra 400022
- Contact
Management
- Mr. Mihir Prakash ShahManaging Director & CEO
- Mr. Binoy Baiju ShahDirector & CFO
- Mr. Harish S PanpaliaInd. Non-Executive Director
- Mr. Yogesh VariaInd. Non-Executive Director
- Mr. Vijay Kumar AyareInd. Non-Executive Director
- Mrs. Ami M ShahNon Executive Woman Director
FAQs on Parnax Lab Share Price
What is the share price of Parnax Lab?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Parnax Lab is ₹129.00 as on Oct 31, 2025.
What kind of stock is Parnax Lab?
The Parnax Lab is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Parnax Lab?
The market cap of Parnax Lab is ₹148.16 Cr as on Oct 31, 2025.
What are today's High and Low prices of Parnax Lab?
Today’s highest and lowest price of Parnax Lab are ₹136.00 and ₹127.35.
What are the 52 Week High and 52 Week Low of Parnax Lab?
The 52-week high/low is the highest and lowest price at which Parnax Lab stock has traded in the past 52-week or nearly a year. The 52-week high of Parnax Lab is ₹193.50 and 52-week low of Parnax Lab is ₹81.00 as on Oct 31, 2025.
How has the Parnax Lab performed historically in terms of returns?
The Parnax Lab has shown returns of -0.31% over the past day, 1.18% for the past month, 3.2% over 3 months, -11.43% over 1 year, 18.41% across 3 years, and 49.45% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Parnax Lab?
P/E ratio of and PB ratio of Parnax Lab are 13.71 and 1.88 on Oct 31, 2025. While the company gives a dividend yield of 0.00 per annum.
✕
Market Pulse